AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34493977 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraearly rehabilitation program (started within 72 hours of onset)
Number of subjects: 86
Study 34493977 — intervention group
Group type: COMPARATOR
Intervention: Early rehabilitation program (started from 72 hours to 7 days after onset)
Number of subjects: 86
Study 35551165 — intervention group
Group type: EXPERIMENTAL
Intervention: FRT with a customized knee BRACE
Number of subjects: 30
Study 35551165 — intervention group
Group type: COMPARATOR
Intervention: TARGET MATCH condition (no resistance applied)
Number of subjects: 30
Study 35551165 — intervention group
Group type: EXPERIMENTAL
Intervention: FRT with elastic BAND
Number of subjects: 30
Study 34087831 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of dexmedetomidine
Number of subjects: 0
Study 34087831 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of 0.9% sodium chloride solution (control)
Number of subjects: 0
Study 32799649 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to daily Occupational Performance approach™ (CO‐OP)
Number of subjects: 12
Study 32799649 — intervention group
Group type: COMPARATOR
Intervention: Traditional occupational therapy
Number of subjects: 12
Study 32799649 — intervention group
Group type: EXPERIMENTAL
Intervention: CO‐OP
Number of subjects: 12
Study 35264213 — intervention group
Group type: EXPERIMENTAL
Intervention: Green-MED diet (supplemented with 28g/day walnuts, daily polyphenol-rich green tea, and Mankai aquatic plant)
Number of subjects: 294
Study 35264213 — intervention group
Group type: EXPERIMENTAL
Intervention: MED diet (supplemented with 28g/day walnuts)
Number of subjects: 294
Study 35264213 — intervention group
Group type: COMPARATOR
Intervention: Healthy dietary guidelines (standard science-based nutritional counseling)
Number of subjects: 294
Study 35614514 — intervention group
Group type: EXPERIMENTAL
Intervention: Shamiri Intervention
Number of subjects: 432
Study 35614514 — intervention group
Group type: COMPARATOR
Intervention: Study-skills active control
Number of subjects: 432
Study 33186897 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen Peptides (15 g/day)
Number of subjects: 15
Study 33186897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 33725433 — intervention group
Group type: EXPERIMENTAL
Intervention: High oxygen concentration (100% O2, non-rebreather mask, 8 L/min)
Number of subjects: 30
Study 33843593 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified digital app with social support features
Number of subjects: 298
Study 33843593 — intervention group
Group type: COMPARATOR
Intervention: Basic digital app with self‐monitoring and goal setting (Control)
Number of subjects: 298
Study 36260487 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-strand hamstring autograft
Number of subjects: 399
Study 36260487 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-strand hamstring autograft
Number of subjects: 399
Study 34429733 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program conducted in 8 sessions, once every week, each session lasting 2.5 hours.
Number of subjects: 67
Study 34429733 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 67
Study 33278743 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic digital intervention
Number of subjects: 632
Study 33028030 — intervention group
Group type: EXPERIMENTAL
Intervention: First-person narrative message
Number of subjects: 525
Study 33028030 — intervention group
Group type: COMPARATOR
Intervention: Third-person narrative message
Number of subjects: 525
Study 33147327 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin 1 g single dose
Number of subjects: 296
Study 33147327 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg twice daily for 7 days
Number of subjects: 296
Study 32004648 — intervention group
Group type: EXPERIMENTAL
Intervention: FMX103 1.5% topical minocycline foam
Number of subjects: 0
Study 32004648 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 34689347 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor sequence learning under explicit learning conditions
Number of subjects: 37
Study 34689347 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor sequence learning under implicit learning conditions
Number of subjects: 37
Study 34689347 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task (DT) conditions with subtracting sevens
Number of subjects: 37
Study 34689347 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task (DT) conditions with verbal fluency
Number of subjects: 37
Study 34689347 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task (DT) conditions with vigilance
Number of subjects: 37
Study 34689347 — intervention group
Group type: COMPARATOR
Intervention: Control group (HC)
Number of subjects: 37
Study 33966407 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention
Number of subjects: 164
Study 33966407 — intervention group
Group type: COMPARATOR
Intervention: Basic nursing intervention
Number of subjects: 164
Study 33098815 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradient boosted model
Number of subjects: 303678
Study 33098815 — intervention group
Group type: COMPARATOR
Intervention: Logistic regression model
Number of subjects: 303678
Study 32492988 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic vaping cigarettes (EVC)
Number of subjects: 20
Study 32492988 — intervention group
Group type: COMPARATOR
Intervention: Heat-not-burn cigarettes (HNBC)
Number of subjects: 20
Study 32492988 — intervention group
Group type: COMPARATOR
Intervention: Both EVC and HNBC
Number of subjects: 20
Study 32492988 — intervention group
Group type: EXPERIMENTAL
Intervention: EVC
Number of subjects: 20
Study 34431238 — intervention group
Group type: EXPERIMENTAL
Intervention: The Good Life intervention (experimental group)
Number of subjects: 182
Study 34431238 — intervention group
Group type: COMPARATOR
Intervention: Wait-list/no-treatment control group
Number of subjects: 182
Study 33669440 — intervention group
Group type: EXPERIMENTAL
Intervention: HCWs in fever clinics
Number of subjects: 1378
Study 33669440 — intervention group
Group type: EXPERIMENTAL
Intervention: Role conflict and ambiguity
Number of subjects: 1378
Study 33669440 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 1378
Study 33669440 — intervention group
Group type: COMPARATOR
Intervention: Regular primary healthcare centers
Number of subjects: 1378
Study 32173633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual trigger group (GnRH agonist and rHCG)
Number of subjects: 0
Study 32173633 — intervention group
Group type: COMPARATOR
Intervention: rHCG group (control)
Number of subjects: 0
Study 35924398 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ionic colloidal silver solution rinse for 6 months as an adjunct to standard oral hygiene regimen
Number of subjects: 80
Study 35924398 — intervention group
Group type: COMPARATOR
Intervention: Standard oral hygiene regimen
Number of subjects: 80
Study 32690763 — intervention group
Group type: EXPERIMENTAL
Intervention: v-gel SGAD
Number of subjects: 14
Study 32690763 — intervention group
Group type: COMPARATOR
Intervention: EEI
Number of subjects: 14
Study 33231778 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) applied to wound surface for 5 minutes after incision
Number of subjects: 76
Study 33231778 — intervention group
Group type: COMPARATOR
Intervention: Normal saline control applied to wound surface for 5 minutes after incision
Number of subjects: 76
Study 36377012 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 57
Study 36377012 — intervention group
Group type: COMPARATOR
Intervention: Sham-Kinesio taping
Number of subjects: 57
Study 32076985 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual acupuncture therapy
Number of subjects: 779
Study 32076985 — intervention group
Group type: COMPARATOR
Intervention: Group acupuncture therapy
Number of subjects: 779
Study 35609328 — intervention group
Group type: EXPERIMENTAL
Intervention: FED (0.25 g·kg‐1 protein and 0.75 g·kg‐1 carbohydrate with 5% l‐[1‐13C]leucine)
Number of subjects: 100
Study 35609328 — intervention group
Group type: EXPERIMENTAL
Intervention: EXFED (0.25 g·kg‐1 protein and 0.75 g·kg‐1 carbohydrate with 5% l‐[1‐13C]leucine after resistance exercise)
Number of subjects: 100
Study 35609328 — intervention group
Group type: EXPERIMENTAL
Intervention: FED
Number of subjects: 100
Study 35609328 — intervention group
Group type: EXPERIMENTAL
Intervention: EXFED
Number of subjects: 100
Study 35609328 — intervention group
Group type: COMPARATOR
Intervention: FAST (only the tracer)
Number of subjects: 100
Study 33683573 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 36
Study 33683573 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 36
Study 35840300 — intervention group
Group type: EXPERIMENTAL
Intervention: Family doctor-led intervention including usual care, medication reminder, 4-week plan, weekly phone interview, and monthly interview.
Number of subjects: 0
Study 35840300 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical services and health education (Control group).
Number of subjects: 0
Study 33557578 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 803
Study 33557578 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 803
Study 36279218 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness app
Number of subjects: 152
Study 36279218 — intervention group
Group type: COMPARATOR
Intervention: Mood-monitoring control
Number of subjects: 152
Study 33273210 — intervention group
Group type: EXPERIMENTAL
Intervention: Continue ART (CTART)
Number of subjects: 557
Study 33273210 — intervention group
Group type: COMPARATOR
Intervention: Discontinue ART
Number of subjects: 557
Study 35984107 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib + exemestane
Number of subjects: 186
Study 35984107 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib + letrozole
Number of subjects: 186
Study 35984107 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib + fulvestrant
Number of subjects: 186
Study 35984107 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib + toremifene
Number of subjects: 186
Study 35984107 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib + anastrozole
Number of subjects: 186
Study 35984107 — intervention group
Group type: COMPARATOR
Intervention: Everolimus pre-treated group
Number of subjects: 186
Study 35984107 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-naïve group
Number of subjects: 186
Study 35984107 — intervention group
Group type: EXPERIMENTAL
Intervention: After propensity score matching
Number of subjects: 186
Study 34226683 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor training (SMT) and resistance training (RT)
Number of subjects: 170
Study 34226683 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 170
Study 32526149 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated devices (ETT, CVC, UC)
Number of subjects: 103
Study 32526149 — intervention group
Group type: COMPARATOR
Intervention: Uncoated devices (ETT, CVC, UC)
Number of subjects: 103
Study 36207154 — intervention group
Group type: EXPERIMENTAL
Intervention: Active medication (multimodal analgesic solution)
Number of subjects: 28
Study 36207154 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 28
Study 33788329 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-session brief intervention (BI)
Number of subjects: 426
Study 33788329 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-session combined intervention (CoI)
Number of subjects: 426
Study 33788329 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 426
Study 32780742 — intervention group
Group type: EXPERIMENTAL
Intervention: Agent-based dynamic process with gendered status concerns
Number of subjects: 0
Study 32780742 — intervention group
Group type: COMPARATOR
Intervention: Control group of agents less influenced by relative status rank
Number of subjects: 0
Study 35474007 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil (FTD/TPI)
Number of subjects: 150
Study 32687801 — intervention group
Group type: EXPERIMENTAL
Intervention: IN-REC-SUR-E (intubate-recruit-surfactant-extubate)
Number of subjects: 218
Study 32687801 — intervention group
Group type: COMPARATOR
Intervention: IN-SUR-E (intubate-surfactant-extubate)
Number of subjects: 218
Study 32687801 — intervention group
Group type: EXPERIMENTAL
Intervention: IN-REC-SUR-E
Number of subjects: 218
Study 32687801 — intervention group
Group type: COMPARATOR
Intervention: IN-SUR-E
Number of subjects: 218
Study 34861170 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimavanserin (20 mg starting dosage, adjustable to 34 mg or 10 mg within the first 8 weeks, administered orally once daily)
Number of subjects: 403
Study 34302927 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 30
Study 34302927 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic Positive Airway Pressure with Assisted Spontaneous Ventilation (BIPAP)
Number of subjects: 30
Study 34302927 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-Controlled Ventilation (VCV)
Number of subjects: 30
Study 34302927 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 30
Study 35798338 — intervention group
Group type: EXPERIMENTAL
Intervention: Training regimen with a live rat every 8 weeks
Number of subjects: 0
Study 35798338 — intervention group
Group type: COMPARATOR
Intervention: Training regimen with a live rat every 6 weeks
Number of subjects: 0
Study 35798338 — intervention group
Group type: COMPARATOR
Intervention: Training regimen with a live rat every 4 weeks
Number of subjects: 0
Study 35798338 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study 32455486 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparative approach
Number of subjects: 25
Study 32455486 — intervention group
Group type: COMPARATOR
Intervention: Morphologic approach
Number of subjects: 25
Study 32461526 — intervention group
Group type: COMPARATOR
Intervention: Control standard formula
Number of subjects: 10
Study 35859621 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30
Study 35859621 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino Acid Combination (AA) (3 g of L-arginine-hydrochloride and 8 g of L-citrulline-malate)
Number of subjects: 30
Study 35859621 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Tea Extract (GTE) (300 mg)
Number of subjects: 30
Study 35859621 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting vs. Post-exercise Measurements
Number of subjects: 30
Study 33384217 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Training System (HTS)
Number of subjects: 20
Study 33384217 — intervention group
Group type: COMPARATOR
Intervention: General Rotator Cuff Exercise with Elastic Band (EB)
Number of subjects: 20
Study 33177278 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascidian-derived plasmalogen (1 mg as plasmalogen) for 12 weeks
Number of subjects: 49
Study 33177278 — intervention group
Group type: COMPARATOR
Intervention: Placebo food for 12 weeks
Number of subjects: 49
Study 36453165 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep-Opt-In
Number of subjects: 14
Study 36453165 — intervention group
Group type: COMPARATOR
Intervention: Healthy Living attention control
Number of subjects: 14
Study 33416271 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min rest protocol
Number of subjects: 9
Study 33416271 — intervention group
Group type: COMPARATOR
Intervention: multivisit protocol
Number of subjects: 9
Study 33211738 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based practices (EBPs) in dispensing OTC medications
Number of subjects: 227
Study 33211738 — intervention group
Group type: EXPERIMENTAL
Intervention: Question: 'Describe your symptoms'
Number of subjects: 227
Study 33211738 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors affecting EBP application
Number of subjects: 227
Study 35733163 — intervention group
Group type: EXPERIMENTAL
Intervention: AT+Vit D
Number of subjects: 48
Study 35733163 — intervention group
Group type: COMPARATOR
Intervention: AT
Number of subjects: 48
Study 35733163 — intervention group
Group type: COMPARATOR
Intervention: Vit D
Number of subjects: 48
Study 35733163 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study 34314347 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure therapy
Number of subjects: 548
Study 34314347 — intervention group
Group type: COMPARATOR
Intervention: Control group (AHI < 5 events/h)
Number of subjects: 548
Study 34314347 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 548
Study 33512328 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberative interaction style CA
Number of subjects: 88
Study 33512328 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternalistic interaction style CA
Number of subjects: 88
Study 32866625 — intervention group
Group type: COMPARATOR
Intervention: Anthracycline/Cyclophosphamide/Taxane (ACTH) or Taxane/Carboplatin (TCH)
Number of subjects: 1770
Study 35363271 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumpstart communication-priming intervention
Number of subjects: 150
Study 35363271 — intervention group
Group type: COMPARATOR
Intervention: Usual care with baseline questionnaires (control)
Number of subjects: 150
Study 32301644 — intervention group
Group type: EXPERIMENTAL
Intervention: dispatcher‐assisted telephone CPR combined with the smartphone-application (telephone + app‐group)
Number of subjects: 150
Study 32301644 — intervention group
Group type: EXPERIMENTAL
Intervention: dispatcher‐assisted telephone CPR with additional verbal motivation and a metronome (telephone + motivation-group)
Number of subjects: 150
Study 32301644 — intervention group
Group type: COMPARATOR
Intervention: dispatcher‐assisted telephone CPR (telephone-group)
Number of subjects: 150
Study 32929906 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous autogenous cBMA+PRP injection
Number of subjects: 66
Study 32929906 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous autogenous bone marrow blood injection (Control)
Number of subjects: 66
Study 32929906 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study 32996239 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum (10 minutes, six times a day)
Number of subjects: 44
Study 32996239 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chewing gum)
Number of subjects: 44
Study 36233611 — intervention group
Group type: EXPERIMENTAL
Intervention: Ellagic Acid (500 mg orally twice a day for 12 weeks)
Number of subjects: 32
Study 34967732 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB) in combination with intra-articular corticosteroid injection (IAI)
Number of subjects: 40
Study 34967732 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular corticosteroid injection (IAI) only
Number of subjects: 40
Study 35000456 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary epinephrine
Number of subjects: 201
Study 35000456 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary adenosine
Number of subjects: 201
Study 33449337 — intervention group
Group type: EXPERIMENTAL
Intervention: ALN-EX (effervescent buffered solution of 70 mg alendronate)
Number of subjects: 360
Study 33449337 — intervention group
Group type: COMPARATOR
Intervention: ALN-T (alendronate tablets)
Number of subjects: 360
Study 33449337 — intervention group
Group type: EXPERIMENTAL
Intervention: ALN-EX
Number of subjects: 360
Study 33449337 — intervention group
Group type: COMPARATOR
Intervention: ALN-T
Number of subjects: 360
Study 35985477 — intervention group
Group type: EXPERIMENTAL
Intervention: SITA Faster (SFR)
Number of subjects: 74
Study 35985477 — intervention group
Group type: COMPARATOR
Intervention: SITA Standard (SS)
Number of subjects: 74
Study 33729273 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia (GA) for both CEA and CABG
Number of subjects: 34
Study 33729273 — intervention group
Group type: COMPARATOR
Intervention: Cervical block anaesthesia (CB) for CEA followed by general anaesthesia (GA) for CABG
Number of subjects: 34
Study 33508736 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT)
Number of subjects: 88
Study 33508736 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete response (CR) after CCRT
Number of subjects: 88
Study 33508736 — intervention group
Group type: EXPERIMENTAL
Intervention: CR after CCRT followed by ACT
Number of subjects: 88
Study 36471982 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine as adjuvant therapy
Number of subjects: 34
Study 36471982 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficacy on TCM syndromes
Number of subjects: 34
Study 36471982 — intervention group
Group type: EXPERIMENTAL
Intervention: Main outcome indicators
Number of subjects: 34
Study 33934471 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% capryloyl glycine and 1% glycine soy‐fermented extract cream (product A)
Number of subjects: 12
Study 33934471 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream (product B)
Number of subjects: 12
Study 36352788 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-glottis (OG) pushing
Number of subjects: 250
Study 36352788 — intervention group
Group type: COMPARATOR
Intervention: Closed-glottis (CG) pushing
Number of subjects: 250
Study 34516703 — intervention group
Group type: EXPERIMENTAL
Intervention: Naringenin (100 mg capsules, twice a day for 4 weeks)
Number of subjects: 44
Study 34516703 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo capsules, twice a day for 4 weeks)
Number of subjects: 44
Study 35733127 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic cognitive behavioral therapy (TCBT) - 10 sessions
Number of subjects: 35
Study 35733127 — intervention group
Group type: COMPARATOR
Intervention: Control group - one session on relaxation and stress-management techniques
Number of subjects: 35
Study 33218555 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy and rehabilitation (PTR) combined with osteopathic management (OSTEO group)
Number of subjects: 18